热门资讯> 正文
Bioceres报告第四季度业绩
2025-09-09 18:08
- Bioceres press release (NASDAQ:BIOX): Q4 net loss was $48.0 million and Adjusted EBITDA1 was negative $4.5 million. For FY25, operating loss was $3.7 million, net loss was $55.2 million and Adjusted EBITDA1 was $28.3 million.
- Revenue of $74.7M (-39.8% Y/Y) misses by $35.38M.
- Net cash flow generated by operating activities reached $29.9 million in 4Q25, and $53.0 million in FY25, a 27% YoY increase from FY24.
More on Bioceres
- Seeking Alpha’s Quant Rating on Bioceres
- Historical earnings data for Bioceres
- Financial information for Bioceres
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
